Bang YJ, Golan T, Dahan L, Fu S, et al. Ramucirumab and durvalumab for previously treated, advanced non-small-cell lung
cancer, gastric/gastro-oesophageal junction adenocarcinoma, or hepatocellular
carcinoma: An open-label, phase Ia/b study (JVDJ). Eur J Cancer 2020;137:272-284.
PMID: 32827847